Article info
PDFClinical science
Acceptability, adherence and economic analyses of a new clinical pathway for the identification of non-responders to glaucoma eye drops: a prospective observational study
- Correspondence to Dr Simon Read, School of Healthcare Sciences, Cardiff University, Cardiff CF24 0AB, UK; readsm{at}cardiff.ac.uk
Citation
Acceptability, adherence and economic analyses of a new clinical pathway for the identification of non-responders to glaucoma eye drops: a prospective observational study
Publication history
- Received October 22, 2019
- Revised January 7, 2020
- Accepted January 30, 2020
- First published March 4, 2020.
Online issue publication
November 23, 2020
Article Versions
- Previous version (23 November 2020).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2020. No commercial re-use. See rights and permissions. Published by BMJ.